Latest Share Consolidation News

Page 3 of 25
HyTerra says it has cut recurring corporate overheads by 30% before new initiatives, or 21% after including them, while reshaping its board and management. The geologic hydrogen explorer is also seeking approval for a 20:1 share consolidation and progressing a sponsored US ADR program without raising new capital.
Maxwell Dee
Maxwell Dee
24 Sept 2026
Xenora Minerals has reduced its annual loss and lifted cash to A$2.17 million while advancing geochemical targets at the Dudley Lithium Project. The next test is whether those anomalies can justify drilling and support the company’s next funding decision.
Maxwell Dee
Maxwell Dee
23 Sept 2026
Terrain Minerals has posted a 54,000-ounce inferred gold resource at Lightning, alongside stronger exploration spending and a reduced FY2026 loss. The next test is whether further drilling, metallurgy and fresh capital can turn the starter resource into something more definitive.
Maxwell Dee
Maxwell Dee
17 Sept 2026
Ionic Rare Earths is pushing toward commercial magnet recycling in Belfast and the United States, but its FY2026 report flags a material uncertainty over its ability to continue as a going concern. The company reported a larger A$14.9 million loss and A$13.9 million in operating cash outflows, despite government support and new strategic partnerships.
Victor Sage
Victor Sage
17 Sept 2026
OMG Group has raised $1.5 million through a placement featuring a $350,000 strategic investment from Slades Beverages, which will become its oat milk manufacturing partner. The company plans a $250,000 Share Purchase Plan and director participation to fuel product launches and supply expansion following a 48% revenue surge in FY26.
Victor Sage
Victor Sage
2 Sept 2026
Eden Innovations Ltd trimmed its loss to $5 million in FY2026 while erasing bank debt and converting loans into equity, supported by property sales and capital raises.
Maxwell Dee
Maxwell Dee
31 Aug 2026
Adherium's FY2026 results show strong revenue gains from US remote patient monitoring but increased losses due to higher operating costs and commercial expansion.
Ada Torres
Ada Torres
31 Aug 2026
BLS Pharmaceuticals (ASX: BLS) reported a standout FY26 with revenue surging 161% to $74.2 million and net profit more than tripling to $15.4 million, driven by expanded manufacturing and major international contracts including a $50 million German supply deal.
Victor Sage
Victor Sage
31 Aug 2026
Alterity Therapeutics posted a 285% jump in revenue to A$1.72 million but also a 93% rise in net loss to A$23.4 million for FY2026. The company secured FDA alignment on a single pivotal Phase 3 trial for ATH434 in Multiple System Atrophy, setting the stage for trial start by year-end.
Ada Torres
Ada Torres
28 Aug 2026
Senetas Corporation reported a 4.7% rise in revenue to $20.2 million for FY2026, achieving a strong $4.4 million operating cash flow turnaround. The company advanced its AI governance platform while maintaining a robust sales pipeline and capital management strategy.
Sophie Babbage
Sophie Babbage
28 Aug 2026
Adherium has tapped its major shareholder, Trudell Medical, for a further AUD 1 million unsecured loan to bolster working capital, adding to a recent USD 1.65 million facility.
Ada Torres
Ada Torres
18 Aug 2026
Klevo Rewards extended its financial services footprint with two acquisitions and proposed a 10:1 share consolidation, while Fly Wallet posted $19 million revenue from an early-stage stablecoin trial in July 2026.
Sophie Babbage
Sophie Babbage
12 Aug 2026

Browse the archive

Full archive